CUSIP: H9060V101
Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / Stock
-
Total 13F shares
-
42,714,192
-
Share change
-
+10,174
-
Total reported value
-
$364,875,713
-
Price per share
-
$8.51
-
Number of holders
-
35
-
Value change
-
+$144,284
-
Number of buys
-
19
-
Number of sells
-
9
Quarterly Holders Quick Answers
What is CUSIP H9060V101?
CUSIP H9060V101 identifies VECT - VECTIVBIO HOLDING - Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q2 2023
-
Previous quarter:
Q4 2022
Recent filing periods for CUSIP H9060V101:
Institutional Holders of VECTIVBIO HOLDING - Stock (VECT) as of Q1 2023
As of 31 Mar 2023,
VECTIVBIO HOLDING - Stock (VECT) was held by
35 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
42,714,192 shares.
The largest 10 holders included
CHI Advisors LLC, ORBIMED ADVISORS LLC, CITADEL ADVISORS LLC, EVENTIDE ASSET MANAGEMENT, LLC, Novo Holdings A/S, TCG Crossover Management, LLC, Bpifrance SA, Cormorant Asset Management, LP, Vivo Capital, LLC, and VR Adviser, LLC.
This page lists
35
institutional shareholders reporting positions in this security
for the Q1 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.